Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.23 - $0.46 $4,614 - $9,229
20,064 New
20,064 $5,000
Q3 2021

Nov 15, 2021

SELL
$1.06 - $1.52 $17,513 - $25,113
-16,522 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$1.22 - $1.65 $27,181 - $36,762
-22,280 Reduced 57.42%
16,522 $25,000
Q1 2021

May 17, 2021

BUY
$1.18 - $2.62 $45,786 - $101,661
38,802 New
38,802 $60,000

About iBio, Inc.


  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.